Skip to main content
. 2019 Jan 17;14(1):e0210476. doi: 10.1371/journal.pone.0210476

Table 3. Reasons for the introduction of DTV/DRV/r.

Reason n
Adverse events
n = 17
Osteopenia/osteoporosis 3
Kidney disorder 5
Hematologic disorders 1
Hypersensitivity reaction to NRTIs 1
Acidosis 1
Polineuropathy 2
Pancreatitis 1
Other intolerance 3
Treatment failure
n = 30
Virologic failure 30
Other reasons
n = 29
Simplification of therapy 27
Other 2
Total 76